SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is buzzing due to recent industry discussions highlighting advanced optical networking for AI and related strategic acquisitions, sparking speculation about its patented interposer technology. The community is intensely focused on POET's platform as a game-changer for hyperscale data centers, citing its efficiency and numerous partnerships with major industry players. Amidst a quiet period from management, investors are keenly anticipating news that could solidify its position at the forefront of the photonics revolution.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is garnering significant attention amid heightened geopolitical interest in Greenland's rare earth deposits, driven by discussions around U.S. national security and securing critical mineral supply chains. The community is buzzing about upcoming high-level meetings between U.S., Danish, and Greenlandic officials, with many speculating on potential U.S. access to these strategic resources and anticipating a substantial upside for CRML's Tanbreez project. Despite recent volatility, investors are actively buying dips, holding strong conviction that CRML, with its large heavy rare earth element deposits, is a key player in reducing Western reliance on foreign suppliers.

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology Company is trending with significant bullish momentum, fueled by strong community sentiment surrounding its role in the U.S. critical minerals and battery recycling sector. Investors are actively discussing the impact of rising lithium prices and the company's strategic positioning amidst government initiatives like the G7 summit on critical metals, anticipating future growth and potential project milestones. Many believe ABAT is poised for substantial appreciation as demand for domestic battery materials heats up.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems is trending amid strong market interest in edge computing solutions for the defense sector, recently bolstered by a new pre-production order from a major U.S. defense contractor. The community is buzzing with anticipation for a much larger situational awareness system contract, viewing the company as a key player in a rapidly expanding industry with a low share float.

Lulu's Fashion Lounge Holdings, Inc. engages in providing an online website for clothing. It offers retailing of women's clothing, shoes, and accessories. The company was founded in 1996 and is headquartered in Chico, CA.

Lulus Fashion Lounge Holdings Inc

Lulus Fashion Lounge Holdings (LVLU) is trending strongly following the disclosure of a 5% activist stake by investor Christian Friedland, who asserts the company is significantly undervalued by up to 27x compared to competitors. The community is actively discussing Friedland's call for governance reforms and the company's recent operational improvements, including positive adjusted EBITDA and expanded gross margins, fueling speculation about a potential substantial upward move for the low-float stock.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is trending due to recent high-grade silver drill results and anticipation for an updated resource estimate in Q1 2026, alongside continued significant investment from Eric Sprott. The community is actively debating the company's vast undeveloped potential amidst a global silver shortage and increasing industrial demand, while also considering the speculative nature and potential for future dilution. This places HYMC at the forefront of discussions regarding domestic precious metal resources in a tightening market.

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

Biodesix Inc

Biodesix (BDSX) is trending after releasing strong preliminary fourth quarter and full-year 2025 results, which reported significant revenue growth and reaffirmed Adjusted EBITDA positivity. This announcement has ignited massive trading volume and a sharp increase in share price, leading to community discussion around a potential short squeeze and significant upside, alongside concerns about future dilution risks.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is heavily trending after securing a multi-year, nine-figure defense contract with the Swedish Armed Forces, significantly boosting its backlog and highlighting strong demand for its space-based data and AI-powered intelligence. The community is buzzing about impressive earnings, recent analyst upgrades, and the company's strategic partnerships, particularly with Google on Project Suncatcher, fueling speculation about its potential as a leading player in the rapidly expanding space and defense sectors.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BNKR is experiencing a surge in attention driven by its AI-powered trading utility on the Base network, alongside active community discussions surrounding its integration with the Coinbase ecosystem. Investors are keenly observing increasing trading volume and speculate on potential major exchange listings, positioning it as an undervalued asset with tight supply and significant upside during the broader altcoin season.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as it moves to accelerate FDA submission for AXPAXLI's wet AMD treatment, aiming for approval based solely on year one SOL-1 Phase 3 data and potentially securing a coveted superiority label. This bold strategy has ignited a fervent community debate, with bulls anticipating a significant re-rating or buyout from major pharma seeking to protect their franchises, while skeptics raise concerns about recent share dilution and the trial's underlying design.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

Looking Into Inovio Pharmaceuticals Inc's Recent Short Interest

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Given Consensus Rating of "Hold" by Analysts

Shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO - Get Free Report) have earned an average recommendation of "Hold" from the nine brokerages that are currently covering the stock, Marketbeat.com...

FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)

FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP) FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of...

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO Reports Inducement Grant Under Inducement Plan INOVIO Reports Inducement Grant Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., Dec. 19, 2025 PLYMOUTH MEETING, Pa., Dec. 19, 2025...

INOVIO to Participate in December Investor Conferences

INOVIO to Participate in December Investor Conferences INOVIO to Participate in December Investor Conferences PR Newswire PLYMOUTH MEETING, Pa., Nov. 18, 2025 PLYMOUTH MEETING, Pa., Nov. 18, 2025...

Inovio (INO) Upgraded to Buy: Here's Why

Inovio (INO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Inovio Pharmaceuticals (NASDAQ:INO) Announces Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Inovio Pharmaceuticals (NASDAQ:INO - Get Free Report) posted its earnings results on Monday. The biopharmaceutical company reported ($0.44) EPS for the quarter, topping the consensus estimate of...

INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights

INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights PR Newswire PLYMOUTH MEETING...

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025 INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025 PR Newswire PLYMOUTH MEETING, Pa., Oct. 27, 2025...

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Inovio Pharmaceuticals Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Current Price	$1.54
Prev Close	$1.56
Open	$1.58
Dividend Yield	0.00%
50-Day Moving Average	$2.02
Beta	1.28
Avg. Volume	1.76M
PE Ratio	-0.60

52-Week High	$2.98
52-Week Low	$1.30
Market Capitalization	$107.18M
EPS (Annual)	-$3.95
Price to Book	-10.69
Revenue Per Employee	$1,625.05
Enterprise Value/EBITDA	N/A

INO
Inovio Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INO News

INOInovio Pharmaceuticals Inc